Empery Asset Management’s Velodyne Lidar, Inc. Warrants VLDRW Stock Holding History

Empery Asset Management’s Portfolio VLDRW Stock Details VLDRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$8K	Hold	18,968	–	–	0.05%	71
2022 Q2	$9K	Hold	18,968	–	–	0.05%	64
2022 Q1	$20K	Sell	18,968 -1,032	-5%	-$1.07K	0.09%	66
2021 Q4	$15K	Buy	+20,000	New	+$25.6K	0.03%	69

Other funds holding VLDRW

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

BHWM

Beaird Harris Wealth Management Dallas, Texas $1.6B AUM 16.64% 1-Year Est. Return

AWM

Abound Wealth Management Franklin, Tennessee $504M AUM 23.73% 1-Year Est. Return

Empery Asset Management's VLDRW Position: Q3 2022 in Review

Empery Asset Management held its Velodyne Lidar, Inc. Warrants (VLDRW) position steady in Q3 2022 at 18,968 shares worth $8K. The position accounts for 0.05% of the portfolio, ranked #71.

Empery Asset Management first reported a position in VLDRW in Q4 2021 and has held it in 4 quarters since. The position peaked at $20K in Q1 2022. 9 funds tracked by Wall St. Rank hold VLDRW as of Q3 2022.

Empery Asset Management held 18,968 shares of Velodyne Lidar, Inc. Warrants worth $8K as of Q3 2022.
Empery Asset Management left its Velodyne Lidar, Inc. Warrants share count unchanged in Q3 2022.
Velodyne Lidar, Inc. Warrants made up 0.05% of Empery Asset Management's portfolio in Q3 2022, its #71 holding.
Empery Asset Management first reported a position in Velodyne Lidar, Inc. Warrants in Q4 2021 and has held it in 4 quarters since.
Empery Asset Management's Velodyne Lidar, Inc. Warrants position peaked at $20K in Q1 2022.
9 funds tracked by Wall St. Rank held Velodyne Lidar, Inc. Warrants as of Q3 2022.

Based on Empery Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.